Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

SourceAllWhite HouseDOJECBBank of JapanFederal ReserveSEC EDGARBank of England
TopicAllenforcementfilingsmonetarypolicy
  • SEC EDGARfilings
    8-K - Keel Infrastructure Corp. (0001812477) (Filer)

    Keel Infrastructure Corp filed a Form 8-K on June 16, 2026, reporting a change in its certifying accountant and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - DYNEX CAPITAL INC (0000826675) (Filer)

    Dynex Capital Inc. filed a Form 8-K on June 16, 2026, disclosing the departure and appointment of certain directors and officers, related compensatory arrangements, and providing accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Global Self Storage, Inc. (0001031235) (Filer)

    Global Self Storage, Inc. filed a Form 8-K with the SEC on June 16, 2026, including Item 5.07 concerning a vote of security holders and Item 9.01 providing financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - LA-Z-BOY INC (0000057131) (Filer)

    La-Z-Boy Inc. filed a Form 8-K on June 16, 2026, including Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGARfilings
    8-K - First Internet Bancorp (0001562463) (Filer)

    First Internet Bancorp filed a Form 8-K on June 16, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.

  • SEC EDGARfilings
    8-K - Norwegian Cruise Line Holdings Ltd. (0001513761) (Filer)

    Norwegian Cruise Line Holdings filed a Form 8-K reporting the departure and appointment of certain officers and directors, related compensatory arrangements, submission of matters to a security-holder vote, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Netcapital Inc. (0001414767) (Filer)

    Netcapital Inc. filed a Form 8-K on June 16, 2026 reporting a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - INTENSITY THERAPEUTICS, INC. (0001567264) (Filer)

    Intensity Therapeutics, Inc. filed a Form 8-K on June 16, 2026 indicating that certain matters have been submitted to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K - Allison Transmission Holdings Inc (0001411207) (Filer)

    Allison Transmission Holdings Inc. filed a Form 8-K on June 16, 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and furnishing financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - MIMEDX GROUP, INC. (0001376339) (Filer)

    Mimedx Group, Inc. filed a Form 8-K reporting amendments to its articles of incorporation and bylaws, a change in fiscal year, and that certain matters were submitted to a vote of security holders.

  • SEC EDGARfilings
    8-K - Vaxcyte, Inc. (0001649094) (Filer)

    Vaxcyte, Inc. filed a Form 8-K on June 16, 2026, indicating that certain matters have been submitted to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K - WEBSTER FINANCIAL CORP (0000801337) (Filer)

    Webster Financial Corp filed a Form 8-K on June 16, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - Opus Genetics, Inc. (0001228627) (Filer)

    Opus Genetics, Inc. filed a Form 8-K on June 16, 2026 (Accession No. 0001140361-26-025440), containing a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - John Marshall Bancorp, Inc. (0001710482) (Filer)

    John Marshall Bancorp, Inc. filed a Form 8-K on June 16 2026, reporting the submission of matters to a vote of security holders (Item 5.07) and providing its financial statements and related exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - SkinHealth Systems Inc. (0001818093) (Filer)

    SkinHealth Systems Inc. filed a Form 8-K on June 16, 2026 indicating that certain matters have been submitted to a vote of its security holders, as required under Item 5.07.

  • SEC EDGARfilings
    8-K - ARCH CAPITAL GROUP LTD. (0000947484) (Filer)

    Arch Capital Group Ltd filed a Form 8-K on June 16, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), with the filing size of 286 KB.

  • SEC EDGARfilings
    8-K - BMO 2026-5C15 Mortgage Trust (0002128774) (Filer)

    BMO 2026-5C15 Mortgage Trust filed a Form 8-K on June 16, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001539497-26-001765.

  • SEC EDGARfilings
    8-K - Omada Health, Inc. (0001611115) (Filer)

    Omada Health, Inc. filed a Form 8-K reporting that it has submitted certain matters to a vote of its security holders.

  • SEC EDGARfilings
    8-K/A - Natera, Inc. (0001604821) (Filer)

    Natera, Inc. filed an amended Form 8-K on June 16, 2026, reporting departures, elections, appointments and compensatory arrangements for certain officers, and providing financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Natera, Inc. (0001604821) (Filer)

    Natera, Inc. filed a Form 8-K reporting the departure and appointment of directors or officers, related compensation arrangements, submission of matters to a shareholder vote, and inclusion of financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Cytek Biosciences, Inc. (0001831915) (Filer)

    Cytek Biosciences, Inc. filed a Form 8-K on June 16, 2026, reporting that it has submitted certain matters to a vote of its security holders, as required under Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer)

    Puma Biotechnology, Inc. filed a Form 8-K on June 16, 2026 reporting that it has submitted certain matters to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K - Century Therapeutics, Inc. (0001850119) (Filer)

    Century Therapeutics, Inc. filed an 8-K reporting the departure of certain officers/directors, the election or appointment of new directors/officers, and disclosed the compensatory arrangements for the appointed officers.

  • SEC EDGARfilings
    8-K - AT&T INC. (0000732717) (Filer)

    AT&T filed a Form 8-K on June 16, 2026 reporting departures, elections and appointments of directors or certain officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGARfilings
    8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    Clover Health Investments, Corp. filed a Form 8-K reporting the departure of certain officers, the election or appointment of directors and officers, and disclosed related compensatory arrangements for those officers.

  • SEC EDGARfilings
    8-K - FiscalNote Holdings, Inc. (0001823466) (Filer)

    FiscalNote Holdings, Inc. filed a Form 8-K reporting that it has entered into a material definitive agreement and disclosed other events.

  • SEC EDGARfilings
    8-K - Everforth Inc (0000890564) (Filer)

    Everforth Inc. filed a Form 8-K on June 16, 2026, including Item 5.07 on matters submitted to a vote of security holders and Item 9.01 containing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - INDEPENDENT BANK CORP (0000776901) (Filer)

    Independent Bank Corp filed a 6 MB Form 8-K on June 16, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits, under accession number 0000776901-26-000110.

  • SEC EDGARfilings
    8-K - Altimmune, Inc. (0001326190) (Filer)

    Altimmune, Inc. filed a Form 8-K with the SEC on June 16, 2026 under Item 8.01 (Other Events), accession number 0001104659-26-074575, comprising 194 KB of information.

  • SEC EDGARfilings
    8-K - Rocket Companies, Inc. (0001805284) (Filer)

    Rocket Companies, Inc. filed a Form 8-K on June 16, 2026, reporting that it has entered into a material definitive agreement, as disclosed in Item 1.01 of the filing.